ReaDySpeech : clinical testing
Research type
Research Study
Full title
ReaDySpeech for people with dysarthria after stroke : intial clinical testing prior to feasibility study
IRAS ID
161003
Contact name
Claire Mitchell
Contact email
Sponsor organisation
University of Manchester
Duration of Study in the UK
0 years, 6 months, 31 days
Research summary
This study is an initial clinical testing for the technology ReaDySpeech. ReaDySpeech has been developed to use with people with dysarthria following stroke and needs to be tested out in clinical practice before the next part of the study which is a feasibility randomised controlled trial. The ethics application for this initial clinical testing will involve asking a minimum of four speech and language therapists to test out the ReaDySpeech technology with two selected patients who have dysarthria following stroke. This initial test phase will help the researchers to find out what training and support is needed to use the ReaDySpeech technology, what clinicians and patients think of it and if any technical amendments need to be made to it. This initial part of the project will enable this information to be taken forward into the next part of the study, the feasibility study for which separate ethics approval will be sought.
REC name
South Central - Oxford B Research Ethics Committee
REC reference
14/SC/1320
Date of REC Opinion
20 Nov 2014
REC opinion
Further Information Favourable Opinion